22 related articles for article (PubMed ID: 8525471)
1. Determination of No-Observed-Adverse-Effect Level Ammonia in White Mice Through CD4 Expression.
Tualeka AR; Faradisha J; Maharja R
Dose Response; 2018; 16(4):1559325818807790. PubMed ID: 30369842
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cytotoxicity and genotoxicity of Inula viscosa leaf extracts with Allium test.
Aşkin Celik T; Aslantürk OS
J Biomed Biotechnol; 2010; 2010():189252. PubMed ID: 20617136
[TBL] [Abstract][Full Text] [Related]
3. Embryotoxicity induced by alkylating agents: 8. DNA adduct formation induced by ethylmethanesulfonate in mouse embryos.
Platzek T; Bochert G; Rahm U
Teratog Carcinog Mutagen; 1994; 14(2):65-73. PubMed ID: 8066548
[TBL] [Abstract][Full Text] [Related]
4. Embryotoxicity induced by alkylating agents: 10. Analysis of the combined teratogenic effects of methylnitrosourea and ethylmethanesulfonate in mice.
Platzek T; Bochert G
Teratog Carcinog Mutagen; 1995; 15(4):201-14. PubMed ID: 8838634
[TBL] [Abstract][Full Text] [Related]
5. DNA alkylation studies of combined treatment with methylnitrosourea and ethylmethanesulfonate in mice.
Platzek T; Bochert G
Teratog Carcinog Mutagen; 2000; 20(1):27-34. PubMed ID: 10607375
[TBL] [Abstract][Full Text] [Related]
6. Embryotoxicity induced by alkylating agents: 5. Dose-response relationships of teratogenic effects of methylnitrosourea in mice.
Platzek T; Bochert G; Pauli B; Meister R; Neubert D
Arch Toxicol; 1988; 62(6):411-23. PubMed ID: 3250372
[TBL] [Abstract][Full Text] [Related]
7. Embryotoxicity induced by alkylating agents: 7. Low dose prenatal-toxic risk estimation based on NOAEL risk factor approach, dose-response relationships, and DNA adducts using methylnitrosourea as a model compound.
Platzek T; Bochert G; Meister R; Neubert D
Teratog Carcinog Mutagen; 1993; 13(3):101-25. PubMed ID: 8105554
[TBL] [Abstract][Full Text] [Related]
8. Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate.
Gocke E; Bürgin H; Müller L; Pfister T
Toxicol Lett; 2009 Nov; 190(3):254-65. PubMed ID: 19857796
[TBL] [Abstract][Full Text] [Related]
9. Procedures for calculating benchmark doses for health risk assessment.
Gaylor D; Ryan L; Krewski D; Zhu Y
Regul Toxicol Pharmacol; 1998 Oct; 28(2):150-64. PubMed ID: 9927564
[TBL] [Abstract][Full Text] [Related]
10. Embryotoxicity induced by alkylating agents: 9. Low dose prenatal-toxic risk estimation of ethylmethanesulfonate based on no-observed-adverse-effect-level risk factor approach, dose-response relationships, and molecular dosimetry.
Platzek T; Bochert G; Meister R
Teratog Carcinog Mutagen; 1995; 15(2):81-92. PubMed ID: 8525471
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
